Teleflex Incorporated
NYSE:TFXMedical - Instruments & Supplies
+$1.04 today
- Market cap
- $6.58B
- Beta
- 0.82
- P/E (TTM)
- -5.5
- EPS (TTM)
- -$22.79
- Dividend yield
- 1.08%
Volume 1.16M
Average 0.80M
TFX Free Cash Flow
Operating cash flow minus capital expenditures: cash available for debt repayment, dividends, and buybacks.
Teleflex IncorporatedNYSE: TFX
Free Cash Flow · Q2 FY2026 · quarter ended Jun 2026
Free cash flow turns positive
Q2 FY2026 free cash flow was $114.73M, compared with -$26.89M a year earlier. Trailing-twelve-month free cash flow was $390.63M. Over 3 fiscal years it compounded at -2.3% a year.
Context
- Free cash flow amounted to 12.3% of revenue in FY2025, down 4.4 pp from a year earlier.
- Free cash flow increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly free cash flow holds near $114.73M or moves back toward the trailing-twelve-month quarterly average of $97.66M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Free Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 245.44M USD
- Year-over-year change
- -51.8%
- 4-year CAGR
- -19.3%
| Period | Period end | Free Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 245.44M | -51.8% |
| FY2024 | 2024-12-31 | 509.31M | +21.5% |
| FY2023 | 2023-12-31 | 419.2M | +59.4% |
| FY2022 | 2022-12-31 | 262.95M | -54.6% |
| FY2021 | 2021-12-31 | 579.8M | — |
Free Cash Flow vs competitors
How TFX compares with its peers on the latest reported figures
- Peers report in different currencies, so free cash flow is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -1.5% is the 7th highest of 11, against a peer median of +14.7%.
- Free cash flow amounts to 15.0% of revenue for TFX, versus a peer median of 15.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.2B USD | +124.8% | +56.0% | — | |
| LTM Jun 2026 | $390.63M USD | -1.5% | -2.3% | 15.0% | |
| LTM Sep 2026 | $376.72M USD | +24.3% | -13.4% | 1496.6% | |
| LTM Jun 2026 | $332.56M USD | -148.8% | — | 33.0% | |
| LTM Sep 2026 | $283.94M USD | -281.0% | -4.9% | 63.0% | |
| LTM Jun 2026 | $257.78M USD | +39.0% | — | 58.5% | |
| LTM Sep 2026 | $252.22M USD | +5.1% | +45.3% | 15.7% | |
| LTM Sep 2026 | $227.37M USD | -53.7% | — | 13.0% | |
| LTM Jun 2026 | $140.33M USD | +185.0% | — | 2.6% | |
| LTM Sep 2026 | $85.56M USD | +221.8% | -47.9% | 9.5% | |
| LTM Jun 2026 | €25.62M EUR | -82.1% | — | 2.1% | |
| Peer median (excluding TFX) | — | +14.7% | -4.9% | 15.7% | |
Competitors are the stored peer set for TFX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 485.37M | 363.14M | 356.33M | 69.68M | 58.53M |
| Depreciation & Amortization | 237.36M | 230.59M | 242.12M | 274.6M | 177.74M |
| Deferred Income Tax | (110.24M) | (13.01M) | (13.05M) | 0 | (100.97M) |
| Stock-Based Compensation | 22.94M | 27.22M | 31.47M | 31.35M | 0 |
| Change in Working Capital | 127.35M | (239.96M) | (111.77M) | (1.82M) | (81.09M) |
| Accounts Receivables | (600K) | (38.46M) | (15.76M) | (27.95M) | (85.53M) |
| Inventory | (11.14M) | (110.69M) | (41.07M) | 1.72M | 84.04M |
| Accounts Payables | 94.02M | (24.79M) | (31.26M) | 9.67M | (8.28M) |
| Other Working Capital | 45.06M | (66.03M) | (23.68M) | 14.74M | (71.31M) |
| Other Non-Cash Items | (111.36M) | (25.84M) | 5.55M | 261.94M | 286.46M |
| Operating Cash Flow | 651.42M | 342.14M | 510.64M | 635.74M | 340.68M |
| Capital Expenditures | (71.62M) | (79.19M) | (91.44M) | (126.43M) | (95.24M) |
| Acquisitions (Net) | 220.32M | (186M) | (588.92M) | (120K) | (825.15M) |
| Purchases of Investments | (18.42M) | (22.3M) | (11.3M) | (7.3M) | (5M) |
| Sales of Investments | 7.3M | 7.3M | 7.3M | 7.3M | 0 |
| Other Investing Activities | 19.15M | 22.24M | 63.13M | 27.2M | 76.19M |
| Investing Cash Flow | 156.74M | (257.94M) | (621.23M) | (99.36M) | (849.19M) |
| Debt Repayment | (634.5M) | (145.45M) | 101.25M | (161.5M) | 982.04M |
| Common Stock Issued | 11.1M | 4.31M | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | (4.31M) | 0 | (200M) | (300M) |
| Dividends Paid | (63.65M) | (63.79M) | (63.9M) | (63.54M) | (60.27M) |
| Other Financing Activities | (28.77M) | (8.27M) | 1.19M | 3.12M | (10.23M) |
| Financing Cash Flow | (715.82M) | (217.51M) | 38.54M | (421.93M) | 611.54M |
| Effect of Forex Changes | (23.13M) | (19.74M) | 2.86M | (9.65M) | (29.35M) |
| Net Change in Cash | 69.2M | (153.05M) | (69.19M) | 104.8M | 73.68M |
| Free Cash Flow | 579.8M | 262.95M | 419.2M | 509.31M | 245.44M |
Teleflex Incorporated
NYSE:TFX
Intrinsic Alpha fair value
Locked
Current Price
$165.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.